Filing Flows › AbbVie (ABBV) › Q4 2025
AbbVie (ABBV) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 20, 2026
AbbVie (ABBV) reported revenue of $16.6B for the fourth quarter 2025 (Q4 2025), +10% from a year earlier and +5% from the quarter before. Operating margin was 27.3%, net earnings $1.8B (10.9% of revenue).
AbbVie, Q4 2025: revenue $16.6B (+10% year over year), operating margin 27.3%, net earnings $1.8B, operating cash flow $5.2B. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.6B | +5% | +10% |
| Gross profit | $12.1B | — | +13% |
| Operating profit | $4.5B | +139% | — |
| Net earnings | $1.8B | +865% | — |
| Operating cash flow | $5.2B | -26% | -26% |
| Free cash flow | $4.9B | -26% | -28% |
What changed
Revenue was $16.6B in Q4 2025, up 10% year over year and up 5% from the previous quarter.
Gross margin was 72.6%, up 1.7 points from a year earlier. Operating profit was $4.5B, a 27.3% margin (up 37.2 points year over year). Operating expenses fell 38% while revenue rose 10%. Net earnings were $1.8B. The effective tax rate was 32.0%.
Operating cash flow was $5.2B (down 26% year over year), 287% of net earnings. Non-cash charges added back $2.0B of depreciation and amortization and $0.16B of share-based compensation. Working capital and other items added $1.3B. Capital expenditures of $0.33B left free cash flow of $4.9B.
Questions
What was AbbVie's revenue in the fourth quarter 2025?
AbbVie (ABBV) reported revenue of $16.6B for the fourth quarter 2025 (Q4 2025), +10% from a year earlier and +5% from the quarter before.
Was AbbVie profitable in the fourth quarter 2025?
Operating profit was $4.5B (27.3% of revenue) and net earnings $1.8B.
Source: AbbVie 10-K on SEC EDGAR.